Learning from failure - rationale and design for a study about discontinuation of randomized trials (DISCO study)
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Background: Randomized controlled trials (RCTs) may be discontinued because of apparent harm, benefit, or futility. Other RCTs are discontinued early because of insufficient recruitment. Trial discontinuation has ethical implications, because participants consent on the premise of contributing to new medical knowledge, Research Ethics Committees (RECs) spend considerable effort reviewing study protocols, and limited resources for conducting research are wasted. Currently, little is known regarding the frequency and characteristics of discontinued RCTs. Methods/Design: Our aims are, first, to determine the prevalence of RCT discontinuation for specific reasons; second, to determine whether the risk of RCT discontinuation for specific reasons differs between investigator- and industry-initiated RCTs; third, to identify risk factors for RCT discontinuation due to insufficient recruitment; fourth, to determine at what stage RCTs are discontinued; and fifth, to examine the publication history of discontinued RCTs. We are currently assembling a multicenter cohort of RCTs based on protocols approved between 2000 and 2002/3 by 6 RECs in Switzerland, Germany, and Canada. We are extracting data on RCT characteristics and planned recruitment for all included protocols. Completion and publication status is determined using information from correspondence between investigators and RECs, publications identified through literature searches, or by contacting the investigators. We will use multivariable regression models to identify risk factors for trial discontinuation due to insufficient recruitment. We aim to include over 1000 RCTs of which an anticipated 150 will have been discontinued due to insufficient recruitment. Discussion: Our study will provide insights into the prevalence and characteristics of RCTs that were discontinued. Effective recruitment strategies and the anticipation of problems are key issues in the planning and evaluation of trials by investigators, Clinical Trial Units, RECs and funding agencies. Identification and modification of barriers to successful study completion at an early stage could help to reduce the risk of trial discontinuation, save limited resources, and enable RCTs to better meet their ethical requirements.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Relaxing the Rule of Ten Events per Variable in Logistic and Cox Regression
Vittinghoff, E., & McCulloch, C. E. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwk052 · Cited by 4,359
Effects of torcetrapib in patients at high risk for coronary events
Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139 · cited 1×
“Reasons for discontinuation of RCTs include unanticipated adverse effects (harm) [1], larger than expected benefit of an intervention (early superiority) [2], or a very low probability of detecting a designated treatment effect with continued patient recruitment or follow-up (futility) [3].”
BackgroundClinical Trial Registration: A Statement from the International Committee of Medical Journal Editors
De Angelis, C., Drazen, J. M., Frizelle, F. A., Haug, C., Hoey, J., Horton, R., Kotzin, S., Laine, C., Marusic, A., Overbeke, A. J. P. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejme048225 · Cited by 1,241
McDonald, A. M., Knight, R. C., Campbell, M. K., Entwistle, V. A., Grant, A. M., Cook, J. A., Elbourne, D. R., Francis, D., Garcia, J., Roberts, I., et al. (2006) · Trials · doi:10.1186/1745-6215-7-9 · Cited by 946
Barriers to Participation in Randomised Controlled Trials
Ross, S., Grant, A., Counsell, C., Gillespie, W., Russell, I., & Prescott, R. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00141-9 · Cited by 907
Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses
Sun, X., Briel, M., Walter, S. D., & Guyatt, G. H. (2010) · BMJ · doi:10.1136/bmj.c117 · Cited by 808 · cited 1×
“As an example, judging the credibility of subgroup effects when reading trial publications is challenging and, following recent recommendations, it is crucial to pre-specify anticipated subgroup effects before the analysis [42].”
BackgroundSelf-citationCampbell, M., Snowdon, C., Francis, D., Elbourne, D., McDonald, A., Knight, R., Entwistle, V, Garcia, J., Roberts, I., Grant, A., et al. (2007) · Health Technology Assessment · doi:10.3310/hta11480 · Cited by 433
Strategies to improve recruitment to randomised controlled trials
Treweek, S., Mitchell, E., Pitkethly, M., Cook, J., Kjeldstrøm, M., Johansen, M., Taskila, T. K., Sullivan, F., Wilson, S., Jackson, C., et al. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000013.pub5 · Cited by 378 · cited 1×
“increasing awareness of the health problem being studied, monetary incentives, using an ‘open label’ rather than placebo design, or making trial materials culturally sensitive [20-22].”
BackgroundStrategies for Increasing Recruitment to Randomised Controlled Trials: Systematic Review
Caldwell, P. H. Y., Hamilton, S., Tan, A., & Craig, J. C. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000368 · Cited by 307 · cited 1×
“increasing awareness of the health problem being studied, monetary incentives, using an ‘open label’ rather than placebo design, or making trial materials culturally sensitive [20-22].”
BackgroundFoy, R. (2003) · Family Practice · doi:10.1093/fampra/20.1.83 · Cited by 160 · cited 2×
“Some studies highlighted the high frequency of recruitment problems in RCTs (Table 1) [5-10].”
Background
Cited by
Prevalence, Characteristics, and Publication of Discontinued Randomized Trials
Kasenda, B., von Elm, E., You, J., Blümle, A., Tomonaga, Y., Saccilotto, R., Amstutz, A., Bengough, T., Meerpohl, J. J., Stegert, M., et al. (2014) · JAMA · doi:10.1001/jama.2014.1361 · Cited by 415
Self-citationDwan, K., Altman, D. G., Clarke, M., Gamble, C., Higgins, J. P. T., Sterne, J. A. C., Williamson, P. R., & Kirkham, J. J. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001666 · Cited by 187
“One study [7,9,10] included 894 protocols (and 520 related journal publications) approved by six research ethics committees from 2000 to 2003 in Switzerland, Germany, and Canada.”
BackgroundKasenda, B., von Elm, E., You, J. J., Blümle, A., Tomonaga, Y., Saccilotto, R., Amstutz, A., Bengough, T., Meerpohl, J. J., Stegert, M., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002046 · Cited by 33
Self-citationStegert, M., Kasenda, B., von Elm, E., You, J. J., Blümle, A., Tomonaga, Y., Saccilotto, R., Amstutz, A., Bengough, T., Briel, M., et al. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.05.023 · Cited by 30
Self-citation
Metadata
- Authors
- Kasenda, B., von Elm, E. B., You, J., Blümle, A., Tomonaga, Y., Saccilotto, R., Amstutz, A., Bengough, T., Meerpohl, J., Stegert, M., Tikkinen, K. A. O., Neumann, I., Carrasco-Labra, A., Faulhaber, M., Mulla, S., Mertz, D., Akl, E. A., Bassler, D., Busse, J. W., Ferreira-González, I., Lamontagne, F., Nordmann, A., Rosenthal, R., Schandelmaier, S., Sun, X., Vandvik, P. O., Johnston, B. C., Walter, M. A., Burnand, B., Schwenkglenks, M., Bucher, H. C., Guyatt, G. H., & Briel, M.
- Venue
- BMC Medical Research Methodology
- Published
- 2012-08-28
- Volume
- 12
- Issue
- 1
- Pages
- 131-131
- ISSN
- 1471-2288 (ISSN-L)
- OpenAlex
- W2101348497
- Cited by
- 36
- References
- 10
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Learning from failure - rationale and design for a study about discontinuation of randomized trials (DISCO study). https://app.cochat.ai/papers/10.1186/1471-2288-12-131
- The paper
- Kasenda, B., von Elm, E. B., You, J., Blümle, A., Tomonaga, Y., Saccilotto, R., Amstutz, A., Bengough, T., Meerpohl, J., Stegert, M., Tikkinen, K. A. O., Neumann, I., Carrasco-Labra, A., Faulhaber, M., Mulla, S., Mertz, D., Akl, E. A., Bassler, D., Busse, J. W., . . . Briel, M. (2012). Learning from failure - rationale and design for a study about discontinuation of randomized trials (DISCO study). BMC Medical Research Methodology. https://doi.org/10.1186/1471-2288-12-131
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.